https://feeds.newsfilecorp.com/company/12230 Latest news from DIMERx INC., as distributed by TMX Newsfile. en CopyRight (c) 2026, Newsfile Corp. All Rights Reserved. office@newsfilecorp.com (Newsfile Corp.) office@newsfilecorp.com (Newsfile Corp.) Sun, 08 Mar 2026 06:34:28 -0400 https://www.newsfilecorp.com/images/newswire/customer-logos/12230.jpg https://feeds.newsfilecorp.com/company/12230 https://www.newsfilecorp.com/release/285996/Jeffrey-W.-Sherman-MD-Joins-DIMERx-Board-to-Advance-NextGeneration-NonAddictive-Pain-Therapies San Francisco, California--(Newsfile Corp. - March 3, 2026) - DIMERx, Inc. ("DIMERx" or "the Company"), is a clinical-stage biopharmaceutical company dedicated to addressing the public-health crisis of drug abuse and dependence, with a portfolio of first-in-class, dimer-based pain therapeutics engineered to deliver effective analgesia without the addiction liabilities of conventional opioids. The Company announced the appointment of Jeffrey W. Sherman, MD, FACP, to its Board of Directors. Dr....<img src="https://api.newsfilecorp.com/newsinfo/285996/156" id="156" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;" /> Tue, 03 Mar 2026 09:00:00 -0500 en https://www.newsfilecorp.com/release/285996